Shinsei Corporate Investment
VC
INVESTOR TYPE
Active
STATUS
5
INVESTMENTS
5
PORTFOLIO
Description
Shinsei Corporate Investment Limited provides both venture investment and buyout investment. The firm's buyout investments are focused on small and medium-sized companies in Japan.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2012
Primary Investor Type
Venture Capital
Other Investor Types
PE/Buyout
Primary Office
- Otemachi Financial City South Tower 16F 1-9-7
- Otemachi, Chiyoda-ku
- Tokyo
- Japan
Shinsei Corporate Investment Investments (5)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Megakaryon | 04-Jan-2018 | Later Stage VC | 000.00 | Other Healthcare Technology Systems | Generating Revenue | |
| 0000000 000 | 16-Aug-2017 | 00000 00000 | 00.000 | Software Development Applications | Generating Revenue | |
| 000000000000 00000 | 05-Jul-2017 | 00000 00000 | 000.00 | Drug Delivery | Clinical Trials - Phase 1 | |
| ChatWork | 19-Jan-2016 | Early Stage VC | 000.00 | Communication Software | Profitable | |
| Mynet (Tokyo) | 12-Feb-2015 | Later Stage VC | 00.00 | Application Software | Generating Revenue |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Shinsei Corporate Investment’s full profile, request a free trial.
Shinsei Corporate Investment Team (1)
| Name | Title | Deals | Funds | Boards | Office | Contact Info |
|---|---|---|---|---|---|---|
| Ippei Matsubara | President & Chief Executive Officer | Tokyo, Japan |
Shinsei Corporate Investment Co-Investors (16)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Innovation Network Corporation of Japan | 2 | 0 | |
| SMBC Venture Capital | 0 | ||
| GMO VenturePartners | 0 | ||
| Otsuka Pharmaceutical | 0 | ||
| Seventure Partners | 0 | 0 |